Enhabit - 3 Year Stock Price History | EHAB
Historical daily share price chart and data for Enhabit since 2022 adjusted for splits and dividends. The latest closing stock price for Enhabit as of November 12, 2025 is 8.05.
- The all-time high Enhabit stock closing price was 25.00 on June 23, 2022.
- The Enhabit 52-week high stock price is 10.90, which is 35.4% above the current share price.
- The Enhabit 52-week low stock price is 6.47, which is 19.6% below the current share price.
- The average Enhabit stock price for the last 52 weeks is 8.28.
| Enhabit Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 8.3424 | 7.7500 | 10.8000 | 6.5200 | 8.0500 | 3.07% |
| 2024 | 8.9576 | 10.1600 | 11.6500 | 6.8900 | 7.8100 | -24.54% |
| 2023 | 12.2134 | 13.0200 | 16.0200 | 7.2800 | 10.3500 | -21.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.404B | $1.035B |
| Enhabit Inc. provides home health and hospice services. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration and skilled observation and assessment services; practices to treat chronic diseases and conditions. Enhabit Inc., formerly known as EHABIT INC, is based in Dallas, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $152.423B | 27.99 |
| HCA Healthcare (HCA) | United States | $105.496B | 17.47 |
| CVS Health (CVS) | United States | $101.390B | 11.66 |
| Cencora (COR) | United States | $70.781B | 22.83 |
| Elevance Health (ELV) | United States | $70.061B | 10.27 |
| Natera (NTRA) | United States | $28.530B | 0.00 |
| DiDi Global (DIDIY) | China | $25.745B | 21.04 |
| Labcorp Holdings (LH) | United States | $22.235B | 16.95 |
| Medpace Holdings (MEDP) | United States | $16.979B | 42.15 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.630B | 0.00 |
| ICON (ICLR) | Ireland | $13.197B | 13.10 |
| Viatris (VTRS) | United States | $12.900B | 4.81 |
| Solventum (SOLV) | United States | $12.814B | 12.44 |
| CochLear (CHEOY) | Australia | $12.308B | 0.00 |
| Revvity (RVTY) | United States | $10.692B | 19.69 |
| HealthEquity (HQY) | United States | $8.601B | 34.42 |
| Charles River Laboratories (CRL) | United States | $8.539B | 16.44 |
| Avantor (AVTR) | United States | $7.841B | 11.98 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.099B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.850B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.116B | 36.46 |
| Bausch + Lomb (BLCO) | Canada | $5.819B | 38.21 |
| Sotera Health (SHC) | United States | $4.582B | 22.10 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $4.044B | 71.02 |
| Alignment Healthcare (ALHC) | United States | $3.298B | 0.00 |
| Concentras Parent (CON) | United States | $2.510B | 15.66 |
| Premier (PINC) | United States | $2.325B | 22.54 |
| Progyny (PGNY) | United States | $2.053B | 40.36 |
| Surgery Partners (SGRY) | United States | $2.036B | 26.24 |
| Ardent Health (ARDT) | United States | $2.011B | 7.76 |
| Establishment Labs Holdings (ESTA) | $1.989B | 0.00 | |
| Organon (OGN) | United States | $1.955B | 2.06 |
| Pediatrix Medical (MD) | United States | $1.942B | 11.60 |
| PACS (PACS) | United States | $1.876B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.342B | 0.00 |
| Omada Health (OMDA) | $1.205B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.053B | 16.83 |
| CareDx (CDNA) | United States | $0.863B | 14.10 |
| Embecta (EMBC) | United States | $0.832B | 4.87 |
| InnovAge Holding (INNV) | United States | $0.735B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.647B | 8.92 |
| Nutex Health (NUTX) | United States | $0.622B | 9.42 |
| Sonida Senior Living (SNDA) | United States | $0.600B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.547B | 0.00 |
| Pomdoctor - (POM) | China | $0.536B | 0.00 |
| Charming Medical (MCTA) | $0.497B | 0.00 | |
| CryoPort (CYRX) | United States | $0.443B | 0.00 |
| So-Young (SY) | China | $0.431B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.412B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.386B | 5.80 |
| SBC Medicals (SBC) | United States | $0.353B | 7.73 |
| Oncology Institute (TOI) | United States | $0.314B | 0.00 |
| KindlyMD (NAKA) | United States | $0.308B | 0.00 |
| Agilon Health (AGL) | United States | $0.257B | 0.00 |
| LifeMD (LFMD) | United States | $0.240B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.231B | 0.00 |
| Beauty Health (SKIN) | United States | $0.166B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.142B | 0.00 |
| DocGo (DCGO) | United States | $0.108B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.101B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.027B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 5.50 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |